Additionally, human studies have demonstrated that individuals with a missense variant (E40K) of Angptl4 have higher insulin sensitivity following a glucose-tolerance test, with reduced probability to develop T2D [33]. This evidence concerns the gene INS and type 2 diabetes mellitus.